Unknown

Dataset Information

0

Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China.


ABSTRACT: Candida haemulonii complex (Candida haemulonii, Candida haemulonii var. vulnera, and Candida duobushaemulonii) consists of emerging pathogens. Thirty-one isolates from 14 hospitals in China were studied for their species classification and antifungal susceptibilities. Performances of molecular (i.e., ribosomal DNA [rDNA] internal transcribed spacer [ITS] sequencing, D1/D2 sequencing, and ITS sequencer-based capillary gel electrophoresis [SCGE]) and phenotypic identification methods in species identification were compared. Twenty-six (83.9%) of 31 isolates were identified as C. haemulonii and 5 isolates were identified as C. duobushaemulonii by ITS sequencing as the reference method; results obtained by D1/D2 sequencing and ITS SCGE were concordant with those obtained by ITS sequencing for all (100%) of the isolates. All 31 isolates were identified as C. haemulonii by the Vitek matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) system (bioMérieux, France), whereas the Bruker MS system (Bruker Daltoniks, Germany) correctly provided species identification for 77.4% and 100% of isolates using cutoff scores for species of ?2.0 and ?1.70, respectively. The Vitek 2 compact (bioMérieux) only identified 9 (29%) of 31 isolates. All isolates showed high MICs for amphotericin B (range, 2 to >8 ?g/ml) and fluconazole (?128 ?g/ml) but low MICs (?0.5 ?g/ml) for the echinocandins. Our results reinforce the need for MALDI-TOF MS and/or molecular differentiation of species within the C. haemulonii complex. The multiresistant antifungal susceptibility profile of these isolates represents a challenge to therapy.

SUBMITTER: Hou X 

PROVIDER: S-EPMC5078542 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China.

Hou Xin X   Xiao Meng M   Chen Sharon C-A SC   Wang He H   Cheng Jing-Wei JW   Chen Xin-Xin XX   Xu Zhi-Peng ZP   Fan Xin X   Kong Fanrong F   Xu Ying-Chun YC  

Journal of clinical microbiology 20160817 11


Candida haemulonii complex (Candida haemulonii, Candida haemulonii var. vulnera, and Candida duobushaemulonii) consists of emerging pathogens. Thirty-one isolates from 14 hospitals in China were studied for their species classification and antifungal susceptibilities. Performances of molecular (i.e., ribosomal DNA [rDNA] internal transcribed spacer [ITS] sequencing, D1/D2 sequencing, and ITS sequencer-based capillary gel electrophoresis [SCGE]) and phenotypic identification methods in species id  ...[more]

Similar Datasets

| S-EPMC11321273 | biostudies-literature
| S-EPMC9760970 | biostudies-literature
| S-EPMC7253641 | biostudies-literature
| S-EPMC4766918 | biostudies-literature
| S-EPMC3405575 | biostudies-literature
| S-EPMC5923090 | biostudies-literature
| S-EPMC6811395 | biostudies-literature
| S-EPMC9936790 | biostudies-literature
| S-EPMC7711680 | biostudies-literature
| S-EPMC5715916 | biostudies-literature